Research Oral Abstract Session - Changes in Drug Use
Tracks
Track 2
Track 3
| Wednesday, October 13, 2021 |
| 4:25 PM - 5:20 PM |
Speaker
Dr. Mary Clare Kennedy
Research Scientist
British Columbia Centre On Substance Use
Fentanyl concentration in drug checking samples and risk of drug-related mortality during an illicit drug toxicity crisis in Vancouver, Canada: a time series analysis
4:30 PM - 4:45 PMBiography
Dr. Mary Clare Kennedy is a Research Scientist at the British Columbia Centre on Substance Use and a Postdoctoral Fellow in the Department of Medicine at the University of British Columbia in Vancouver, Canada.
Scott McDonald
Senior Research Fellow
School of Health and Life Sciences, Glasgow Caledonian University
Increasing Drug-related Mortality Over The Last Decade Among Scotland's HCV-diagnosed PWID Population
4:45 PM - 5:00 PMBiography
Scott McDonald is a epidemiologist/biostatistician at Glasgow Caledonian University and has contributed to numerous studies among hepatitis C virus infected and drug-using populations in Scotland and elsewhere since 2006.
Dr Sophia Schroeder
Researcher
Burnet Insitute
Injecting as a social practice: illuminating the party-and-play practice bundle among gay and bisexual men in Australia
5:00 PM - 5:15 PMBiography
Sophia holds an MPH and is currently pursuing a PhD with Monash University. Her research topics range from hepatitis C elimination to supporting the wellbeing of substance-using populations. She draws primarily on qualitative methodologies to explore the space in between individuals and society, illuminating processes that contribute to ill-health.
Dr Xiao Zang
Postdoctoral Research Associate
School of Public Health, Brown University
The impact of syringe services program closure on the risk of rebound HIV outbreaks among people who inject drugs: a modelling study
5:15 PM - 5:20 PMBiography
Xiao Zang, PhD, is a Postdoctoral Research Associate in the Department of Epidemiology at Brown University School of Public Health. His research primarily focuses on the prevention and treatment for HIV/AIDS and opioid overdose mortality using simulation modeling methods and health economic evaluations.
Chair
Adrian Dunlop
Director, Senior Staff Specialist
Drug & Alcohol Clinical Services, HNE Health
Rachel Sutherland
Research Fellow
NDARC
Speaker - will not appear in Portal
Mary Clare Kennedy
Research Scientist
British Columbia Centre On Substance Use
Scott McDonald
Senior Research Fellow
School of Health and Life Sciences, Glasgow Caledonian University
Sophia Schroeder
Researcher
Burnet Insitute
Xiao Zang
Postdoctoral Research Associate
School of Public Health, Brown University
